IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Sensibio® in 30 g. new package.
Sensibio® 30 g. new package was launched to the market in order to complete Sensibio® 15 g., the well-established fixed combination of Fusidic acid (antibiotic) and Betamethasone Valerate (anti-inflammatory & antipruritict action). Each gram of Sensibio contains 20 mg Fusidic acid & 1 mg Betamethasone.
Sensibio® is indicated for inflammatory dermatoses where bacterial infection is present or likely to occur, such as: atopic eczema, discoid eczema, seborrheic dermatitis, contact dermatitis, chronic lichenoid eczema, psoriasis, and discoid lupus erythematosus.
Active ingredient: Fusidic acid & Betamethasone valerate
Form / Content
Cream for dermatological use (tube of 15 & 30 g).
1 g contains combination of 20 mg Fusidic acid and 1 mg Betamethasone valerate.
